Author:
Klimentova E. A.,Gilyazova I. R.,Bermisheva M. A.,Blinnikova A. M.,Safiullin R. I.,Izmailov A. A.,Yang B.,Pavlov V. N.,Khusnutdinova E. K.
Reference28 articles.
1. Mohammadian, M., Pakzad, R., Towhidi, F., et al., Incidence and mortality of kidney cancer and its relationship with HDI (Human Development Index) in the world in 2012, Clujul Med., 2017, vol. 90, no. 3, pp. 286—293. https://doi.org/10.15386/cjmed-691
2. Kaprin, A.D., Starinskii, V.V., and Petrova, G.V., Zlokachestvennye novoobrazovaniya v Rossii v 2016 g. (zabolevaemost’ i smertnost’) (Malignant Neoplasms in Russia in 2016 (Morbidity and Mortality)), Moscow: Mosk. Nauchno-Issled. Inst. im. P.A. Gertsena, 2018.
3. Audenet, F., Yates, D.R., Cancel-Tassin, G., et al., Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine, BJU Int., 2011, vol. 109, pp. 1864—1870. https://doi.org/10.1111/j.1464-410X.2011.10661.x
4. Vanharanta, S., Shu, W., Brenet, F., et al., Epigenetic expansion of VHL-HIF signal output drives multi-organ metastasis in renal cancer, Nat. Med., 2013, vol. 19, no. 1, pp. 50—56. https://doi.org/10.1038/nm.3029
5. Kondo, K., Klco, J., Nakamura, E., et al., Inhibition of HIF is necessary for tumor suppression by the von Hippel—Lindau protein, Cancer Cell, 2002, vol. 1, pp. 237—246.